findmyKOL

Eduardo Braun, MD

Basic profile

SimBiotic Software

ORCIDNone on fileNPI
RegionWestville, IN · MidwestSpecialtyMedical OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Eduardo Braun is an Oncology physician affiliated with SimBiotic Software. OpenAlex indexes 41 publications with 207 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
41publications

Distinct works indexed by OpenAlex.

207citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
57companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1668 S Us Highway 421
Westville, IN 463919523

Telephone

800-860-8100

Registry record last updated 3 Jan 2018.

View the NPPES registry record

Industry payments

57 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Blood & clotting

    38.9%
    Erythropoiesis-stimulating Agent31.1%
    Darbepoetin alfa100%
    Part B, office-administered15 patients
    Iron, parenteral preparations7.6%
    Ferric derisomaltose100%
    Part B, office-administered23 patients

    + 1 more class in this area

  • Cancer & immunology

    29%
    PD-1 inhibitor27.7%
    Pembrolizumab100%
    Part B, office-administered13 patients
    Platinum-based Drug0.6%
    Carboplatin100%
    Part B, office-administered11 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    19%
    Substance P/Neurokinin-1 Receptor Antagonist16.5%
    Aprepitant100%
    Part B, office-administered13 patients
    Serotonin-3 Receptor Antagonist2%
    Palonosetron hcl94%Ondansetron Odt6%
    Part D + Part B21 patients

    + 4 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”